Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Appointed director
Quarterly results
Director departure
Inv. presentation
|
|
China Biologic Products Holdings, Inc. (CBPO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/15/2021 |
SC 13D
| CPEChina Fund III, L.P. reports a 9.7% stake in China Biologic Products Holdings, Inc. |
| 09/23/2020 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 09/30/2019 |
SC 13D
| Temasek Holdings Ltd reports a 2.6% stake in China Biologic Products Holdings, Inc. |
| 09/19/2019 |
SC 13D
| Hillhouse Capital Advisors, Ltd. reports a 7.2% stake in China Biologic Products Holdings, Inc. |
| 09/14/2018 |
SC 13D
| Centurium Capital Partners 2018, L.P. reports a 7.9% stake in China Biologic Products Holdings, Inc. |
| 08/20/2018 |
SC 13D
| GL CAPITAL MANAGEMENT GP Ltd reports a 5.6% stake in China Biologic Products Holdings, Inc. |
| 08/20/2018 |
SC 13D
| Gao David reports a 1.3% stake in China Biologic Products Holdings, Inc. |
| 06/18/2018 |
SC 13D
| CITIC Capital Holdings Ltd reports a 5.1% stake in China Biologic Products Holdings, Inc. |
| 01/10/2018 |
SC 13D
| PW Medtech Group Ltd reports a 16.7% stake in China Biologic Products Holdings, Inc. |
| 11/24/2010 |
SC 13D
| Essence International Investment Ltd has filed a Schedule 13D for China Biologic Products, Inc. |
| 11/24/2010 |
SC 13D
| China Biologic Products, Inc. reports a 6.9% stake in China Biologic Products, Inc. |
| 09/13/2007 |
SC 13D
| Zhao Chao Ming reports a 5% stake in CHINA BIOLOGIC PRODUCTS, INC. |
| 09/12/2007 |
SC 13D
| CHAN LING SIU reports a 32% stake in CHINA BIOLOGIC PRODUCTS, INC. |
| 09/12/2007 |
SC 13D
| Li Lin Ling reports a 32% stake in CHINA BIOLOGIC PRODUCTS, INC. |
|
|